Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy
Giovanni Corrao, Gloria Porcu, Alina Tratsevich, Danilo Cereda, Giovanni Pavesi, Guido Bertolaso, Matteo Franchi

TL;DR
The study estimates how many deaths were prevented by the first two years of the COVID-19 vaccination campaign in Italy.
Contribution
It introduces a method using excess all-cause deaths to evaluate vaccination impact in three Italian regions.
Findings
Lombardy had the highest prevented fraction of deaths (65%) but a lower rate of averted deaths compared to Marche and Sicily.
Excess mortality rates varied across regions, with Marche having the highest at 24 per 10,000 person-years.
Early and full vaccination implementation in Lombardy was linked to the largest reduction in all-cause deaths.
Abstract
Comparing deaths averted by vaccination campaigns is a crucial public health endeavour. Excess all-cause deaths better reflect the impact of the pandemic than COVID-19 deaths. We used a seasonal autoregressive integrated moving average with exogenous factors model to regress daily all-cause deaths on annual trend, seasonality, and environmental temperature in three Italian regions (Lombardy, Marche and Sicily) from 2015 to 2019. The model was used to forecast excess deaths during the vaccinal period (December 2020–October 2022). We used the prevented fraction to estimate excess deaths observed during the vaccinal campaigns, those which would have occurred without vaccination, and those averted by the campaigns. At the end of the vaccinal period, the Lombardy region proceeded with a more intensive COVID-19 vaccination campaign than other regions (on average, 1.82 doses per resident,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · COVID-19 epidemiological studies · Vaccine Coverage and Hesitancy
